NCT00832325

Brief Summary

The purpose of this study is to better understand how the illness has affected the identity and what needs the survivor may have. We hope that this information will help us provide better care to future adolescent and young adult cancer survivors.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jan 2009Jan 2027

Study Start

First participant enrolled

January 1, 2009

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

January 28, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 30, 2009

Completed
17.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

March 3, 2026

Status Verified

March 1, 2026

Enrollment Period

18 years

First QC Date

January 28, 2009

Last Update Submit

March 2, 2026

Conditions

Cancer

Keywords

Childhood SurvivorsurvivorsYoung Adult Cancer SurvivorsChildhood cancers09-001

Outcome Measures

Primary Outcomes (1)

  • Conduct a comprehensive qualitative assessment through individual interviews and focus groups of identity development, peer and family relationships, and psychosocial concerns among survivors diagnosed during adolescence.

    3 years

Secondary Outcomes (1)

  • Conduct a prospective longitudinal assessment of identity development and peer and family relationships among survivors diagnosed during adolescence.

    3 years

Study Arms (3)

1 individual interviews

The patient will be asked to come in to the Counseling Center at MSKCC (641 Lexington Avenue, 7th Floor) and participate in an individual interview at their convenience.

Behavioral: interview

2 Focus Groups

The patient will be asked to come in to the Counseling Center at MSKCC (641 Lexington Avenue, 7th Floor) and participate in a focus group at their convenience.

Behavioral: Focus groups

3 Questionnaire

The patient will be asked to participate in three 60-90 minute telephone interviews scheduled at their convenience.

Behavioral: Questionnaire

Interventions

interviewBEHAVIORAL

The doctor and/or one of her trained research study staff will ask the patient about their experience as an adolescent/young adult cancer survivor, their health and quality of life. It should take (approximately 1-1 ½ hours)to complete. Interviews will be audiotaped and transcribed by a professional transcription service.

1 individual interviews
Focus groupsBEHAVIORAL

The patient will participate with 6-8 other adolescent/young adult cancer survivors. The doctor and/or her trained research study staff will ask about their experience as an adolescent/young adult cancer survivor, their health and quality of life. It should take about one-and-a-half hour to complete. Focus groups will be audio taped and transcribed by a professional transcription service.

2 Focus Groups
QuestionnaireBEHAVIORAL

The patient will be asked to participate in three 60-90 minute telephone interviews conducted by the doctor and/or her trained research study staff scheduled at the patient's convenience, the second interview approximately 6-8 months after the first and the last interview approximately 12-16 months after the first. The questionnaire will ask about their experience as an adolescent/young adult cancer survivor, their health and quality of life.

3 Questionnaire

Eligibility Criteria

Age15 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

adolescent survivors from MSKCC

You may qualify if:

  • Current age greater than and including 15 and up to and including 25 years of age at time of consent
  • Diagnosis of a first cancer \> or = to 14 and up to and including 21 years of age
  • At least 6 months post-treatment according to participant's self-report.
  • Able to provide informed consent (or parent or legal guardian consent and participant assent for those participants under 18 years of age)

You may not qualify if:

  • Will exclude survivors with severe cognitive impairment that precludes them from being able to give information consent and/or complete the questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Interviews as TopicFocus GroupsSurveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Marie Barnett, PhD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2009

First Posted

January 30, 2009

Study Start

January 1, 2009

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

March 3, 2026

Record last verified: 2026-03

Locations

US(1)